HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice.

AbstractBACKGROUND:
Whether left ventricular hypertrophy (LVH) in obesity results from increased hemodynamic load or altered neurohormonal signaling remains controversial. Dysregulation of leptin, a neurohormone essential to energy homeostasis, is implicated in the pathogenesis of obesity. Because leptin has cardiovascular bioactivity, we hypothesized that disruption of leptin signaling mediates the development of obesity-associated LVH.
METHODS AND RESULTS:
We measured left ventricular (LV) wall thickness and LV mass with echocardiography in mice lacking leptin (ob/ob, n=15) or functional receptor (db/db, n=10) and controls at 2, 4, and 6 months of age. None of the mice had LVH at 2 months. Progressive obesity developed in ob/ob and db/db mice. At 6 months, LVH occurred in ob/ob and db/db compared with controls. We observed corresponding myocyte hypertrophy by light microscopy. To separate the direct contribution of leptin deficiency from mechanical effects of obesity, we induced weight loss in 6- to 8-month-old ob/ob mice either by leptin infusion or caloric restriction. Mice in both groups lost similar weight compared with placebo-treated controls. Leptin infusion completely reversed the increase in wall thickness with partial resolution of myocyte hypertrophy, whereas calorie-restricted mice had no decrease in wall thickness and a lesser change in myocyte size.
CONCLUSIONS:
Together these data show that the effect of leptin on LV remodeling is not attributable to weight loss alone, indicating that leptin has antihypertrophic effects on the heart, either directly or through a leptin-regulated neurohumoral pathway. Disruption of leptin signaling may represent a novel mechanism in LVH and related cardiovascular disorders.
AuthorsLili A Barouch, Dan E Berkowitz, Robert W Harrison, Christopher P O'Donnell, Joshua M Hare
JournalCirculation (Circulation) Vol. 108 Issue 6 Pg. 754-9 (Aug 12 2003) ISSN: 1524-4539 [Electronic] United States
PMID12885755 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Leptin
  • Receptors, Cell Surface
  • Receptors, Leptin
  • leptin receptor, mouse
Topics
  • Animals
  • Body Weight (genetics)
  • Cardiomegaly (complications, genetics, pathology)
  • Disease Models, Animal
  • Disease Progression
  • Heart Ventricles (pathology)
  • Hemodynamics
  • Homozygote
  • Leptin (deficiency, genetics)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Mutant Strains
  • Myocardium (pathology)
  • Myocytes, Cardiac (pathology)
  • Obesity (complications, genetics)
  • Organ Size (genetics)
  • Receptors, Cell Surface (deficiency, genetics)
  • Receptors, Leptin
  • Signal Transduction
  • Ventricular Remodeling (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: